Skip to main content

sodium

Generic: SODIUM CHLORIDE·Brand: BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, BRONCHO SALINE, MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE, Nebusal, OSMOPREP, SODIUM ACETATE, SODIUM CHLORIDE, SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE 0.9%, SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE 0.9% IN PLASTIC THERMOJECT KIT FOR CARDIAC OUTPUT USE, SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER, SODIUM CHLORIDE 14.6%, SODIUM CHLORIDE 23.4%, SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER, SODIUM CHLORIDE 3% IN PLASTIC CONTAINER, SODIUM CHLORIDE 5% IN PLASTIC CONTAINER, SODIUM CHLORIDE IN PLASTIC CONTAINER, SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE IN PLASTIC CONTAINER, SODIUM PHOSPHATES, SODIUM PHOSPHATES IN PLASTIC CONTAINER, SODIUM SUCCINATE, Saljet, VISICOL

sodium: developed by 2 companies · 9 clinical trials tracked · 2 FDA decisions.

sodium evidence translation

What we can confirm

2 FDA records · 9 tracked trials

What it means

More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

What is verified about sodium, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 5 study sponsors

Related indications

Use For dry nasal membranesAtopic DermatitisEczema
Development Pipeline (3)
CompanyPhase
Grifols S.A. (GRFS)Approved
NEXUS BIOPHARMA INC (NEXS)
Use For dry nasal membranes
Approved
NEXUS BIOPHARMA INC (NEXS)Approved
Clinical Trials (9)

A Randomized, Double-Blind, Phase 2, Efficacy and Safety Study of Allogeneic HB-adMSCs vs Placebo for the Treatment of Crohn's Disease

NCT07077746·Phase 2·GHRS
Recruiting

Primary endpoint: Changes from Baseline in Crohns Disease Activity Index (CDAI) Scores.

InterventionalRandomizedquadruple46 targetStarted 2026-07Completion 2027-121 site · United StatesHope Biosciences Research Foundation

The Impact of Dietary Salt on the Severity of Eczema

NCT07447063·Phase 4
Not yet recruiting

Primary endpoint: Eczema severity

InterventionalRandomizedtriple40 targetStarted 2026-06Completion 2028-052 sites · United StatesUniversity of California, San Francisco

Effect of Push-Dose Adrenaline on Peri-intubation Cardiovascular and Clinical Outcomes During Rapid Sequence Intubation in the Emergency Department: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

NCT07620327·Phase 4
Not yet recruiting

Primary endpoint: Peri-intubation hypotension

InterventionalRandomizedquadruple128 targetStarted 2026-06Completion 2026-121 site · Turkey (Türkiye)Marmara University Pendik Training and Research Hospital

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD (COPD-OMA)

NCT07059091·Phase 2
Recruiting

Primary endpoint: Rate of COPD exacerbations

InterventionalRandomizedtriple334 targetStarted 2026-02Completion 2031-0523 sites · United StatesJohns Hopkins University

A Randomized, Double-blind, Placebo-controlled, 104-week Proof-of-concept Study to Evaluate the Efficacy of Intravenous Prasinezumab in Participants With Parkinson's Disease Carrying a Severe Mutation in the GBA Gene

NCT07055087·Phase 2·PRTA
Not yet recruiting

Primary endpoint: Parkinson's Disease Cognitive Composite Score (PDCCS)

InterventionalRandomizedquadruple120 targetStarted 2025-12Completion 2031-058 sites · France, Germany, Italy, Luxembourg…University Hospital Tuebingen

Copenhagen Menopause Study (COMPASS): A Randomized Clinical Trial

NCT07254429·Phase 2·CDTX
Recruiting

Primary endpoint: Change in bone remodeling from baseline to week 8.

InterventionalRandomizedsingle192 targetStarted 2025-10Completion 2028-051 site · DenmarkMartin Blomberg Jensen

Effect of Medial Transversus Abdominis Plane (TAP) Block and Rectus Sheath (RS) Block on Inguinal Hernia Surgery Recovery, a Prospective Randomized Double-blind Study (PRO-RSTAP)

NCT07423910·N/A·CRNX
Recruiting

Primary endpoint: Total cumulative opioid consumption (intravenous morphine equivalent dose, mg)

InterventionalRandomizedquadruple200 targetStarted 2025-07Completion 2038-011 site · FinlandTampere University Hospital

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Adeno-associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Patients With Late-onset OTC Deficiency

NCT05345171·Phase 3·RARE
Active, not recruiting

Primary endpoint: Plasma Ammonia as Measured by 24-Hour Ammonia (AUC0-24)

InterventionalRandomizedquadruple37 targetStarted 2022-10Completion 2031-0316 sites · Argentina, Brazil, Canada, France…Ultragenyx Pharmaceutical Inc

Calcium Administration in Patients Undergoing Cardiac Surgery Under Cardiopulmonary Bypass (ICARUS Trial): Prospective Randomized, Double-blind Placebo-controlled Superiority Trial

NCT03772990·Phase 4·GHRS
Completed

Primary endpoint: Inotropic support

InterventionalRandomizedquadruple820 enrolledStarted 2019-01Completion 2025-0811 sites · Bahrain, Russia, Saudi ArabiaMeshalkin Research Institute of Pathology of Circulation
FDA Decisions2 records
Approval(NEXS)FDA ↗
ANDA217535UNKNOWNStandardOtherSolution
ApprovalINDICATIONS AND USAGE Sodium Chloride Injection, USP is indicated as a source of water and electrolytes. 0.9% Sodium Chloride Injection, USP is also indicated for use as a priming solution in hemodialysis procedures.(GRFS)FDA ↗
ANDA207956UNKNOWNStandardOtherInjectable

Frequently asked questions

Who is developing sodium?

sodium is being developed by Grifols S.A., NEXUS BIOPHARMA INC.

How many clinical trials involve sodium?

BioSniper tracks 9 clinical trials involving sodium.

What is sodium's latest FDA decision?

The most recent tracked FDA decision for sodium is Approval, dated August 23, 2023.